UROCIT-K 5 MEQ Extended Release Oral Tablet

RxCUI: 603282
RxNorm name: UROCIT-K 5 MEQ Extended Release Oral Tablet
Display name: UROCIT-K 5 MEQ Extended Release Oral Tablet
Full name: UROCIT-K 5 MEQ Extended Release Oral Tablet
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:03

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
UROCIT-K	POTASSIUM CITRATE	Mission Pharmacal Company	72cdea1b-2240-41db-987d-86d5c6aaa978	2021-12-02	Warnings, Adverse reactions	Exact identifier rxcui: 603282

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
72cdea1b-2240-41db-987d-86d5c6aaa978	UROCIT-K 5 MEQ Extended Release Oral Tablet [PSN] · potassium citrate 5 MEQ Extended Release Oral Tablet [Urocit-K] [SBD] · K+ citrate 5 MEQ Extended Release Oral Tablet [Urocit-K] [SY] · Pot citrate 5 MEQ Extended Release Oral Tablet [Urocit-K] [SY] · Urocit-K 5 MEQ Extended Release Oral Tablet [SY]	5	28	Urocit ®-K (Potassium Citrate) Extended Release Tablets for Oral Use These highlights do not include all the information needed to use Urocit ® -K safely and effectively. See full prescribing information for Urocit ® -K. Initial U.S. Approval: 1985	20251202